4
Changes in Ownership
Kymera Therapeutics, Inc. Filed Acc 0001415889-24-019440
Director sold 453,960 shares at an average $38.21 ($17,346,919)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Booth Bruce · Director
Table I: Non-derivative
10 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-07-09 | Sale : show line 1 in the form 10b5-1 | −24,449 | $35.57 | $869,651 | 4,523,951 | I |
| 2024-07-09 | Sale : show line 2 in the form 10b5-1 | −28,718 | $36.40 | $1,045,335 | 4,495,233 | I |
| 2024-07-09 | Sale : show line 3 in the form 10b5-1 | −41,763 | $37.41 | $1,562,354 | 4,453,470 | I |
| 2024-07-09 | Sale : show line 4 in the form 10b5-1 | −183,868 | $38.48 | $7,075,241 | 4,269,602 | I |
| 2024-07-09 | Sale : show line 5 in the form 10b5-1 | −96,386 | $39.26 | $3,784,114 | 4,173,216 | I |
| 2024-07-09 | Sale : show line 6 in the form 10b5-1 | −5,133 | $35.57 | $182,581 | 796,889 | I |
| 2024-07-09 | Sale : show line 7 in the form 10b5-1 | −6,030 | $36.40 | $219,492 | 790,859 | I |
| 2024-07-09 | Sale : show line 8 in the form 10b5-1 | −8,769 | $37.41 | $328,048 | 782,090 | I |
| 2024-07-09 | Sale : show line 9 in the form 10b5-1 | −38,606 | $38.48 | $1,485,559 | 743,484 | I |
| 2024-07-09 | Sale : show line 10 in the form 10b5-1 | −20,238 | $39.26 | $794,544 | 723,246 | I |
| Open-market sales · 453,960 sh · avg $38.21 · $17,346,919 | ||||||
Loading xslF345X05/form4-07092024_090724.xml…